Patents by Inventor Toby Wilson Waterworth

Toby Wilson Waterworth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATION
    Publication number: 20220119819
    Abstract: The present invention relates to a new formulation of the oligonucleotide of SEQ ID NO: 1.
    Type: Application
    Filed: January 6, 2022
    Publication date: April 21, 2022
    Inventors: Toby Wilson Waterworth, Lorin Johnson, Janette Thomas, Michael Webb
  • Formulation
    Patent number: 11220690
    Abstract: The present invention relates to a new formulation of the oligonucleotide of SEQ ID NO:1.
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: January 11, 2022
    Assignee: Atlantic Pharmaceuticals (Holdings) LTD
    Inventors: Toby Wilson Waterworth, Lorin Johnson, Janette Thomas, Michael Webb
  • NEW FORMULATION
    Publication number: 20190367927
    Abstract: The present invention relates to a new formulation of the oligonucleotide of SEQ ID NO:1.
    Type: Application
    Filed: January 8, 2018
    Publication date: December 5, 2019
    Inventors: Toby Wilson Waterworth, Lorin Johnson, Janette Thomas, Michael Webb
  • Antisense treatment of radiation induced diseases in the gastrointestinal tract
    Patent number: 10059948
    Abstract: This invention relates to a composition comprising an antisense oligonucleotide for use in treating radiation induced disease of the gastrointestinal tract.
    Type: Grant
    Filed: May 1, 2015
    Date of Patent: August 28, 2018
    Assignee: Atlantic Pharmaceuticals (Holdings) Ltd.
    Inventor: Toby Wilson Waterworth
  • ICAM-1 antisense for the treatment of inflammation and pain in a rectal stump
    Patent number: 9453221
    Abstract: This invention relates to a composition comprising an antisense oligonucleotide that down-regulates intracellular adhesion molecule-1 (ICAM-1) for use in treating inflammation, pain and/or discharge in a rectal stump.
    Type: Grant
    Filed: June 3, 2013
    Date of Patent: September 27, 2016
    Assignee: ATLANTIC PHARMACEUTICALS (HOLDINGS) LTD
    Inventors: Toby Wilson Waterworth, Huw Jones
  • AN ICAM-1 ANTISENSE FOR THE TREATMENT OF INFLAMMATION AND PAIN IN A RECTAL STUMP
    Publication number: 20150337301
    Abstract: This invention relates to a composition comprising an antisense oligonucleotide that down-regulates intracellular adhesion molecule-1(ICAM-1) for use in treating inflammation, pain and/or discharge in a rectal stump.
    Type: Application
    Filed: June 1, 2013
    Publication date: November 26, 2015
    Applicant: ATLANTIC PHARMACEUTICALS (HOLDINGS) LTD
    Inventors: Toby Wilson Waterworth, Huw Jones